GLSI
Price
$29.00
Change
+$3.81 (+15.13%)
Updated
Feb 6 closing price
Capitalization
400.26M
17 days until earnings call
Intraday BUY SELL Signals
MIRM
Price
$100.47
Change
+$2.24 (+2.28%)
Updated
Feb 6 closing price
Capitalization
6.01B
31 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

GLSI vs MIRM

Header iconGLSI vs MIRM Comparison
Open Charts GLSI vs MIRMBanner chart's image
Greenwich LifeSciences
Price$29.00
Change+$3.81 (+15.13%)
Volume$302.89K
Capitalization400.26M
Mirum Pharmaceuticals
Price$100.47
Change+$2.24 (+2.28%)
Volume$588.73K
Capitalization6.01B
GLSI vs MIRM Comparison Chart in %
GLSI
Daily Signal:
Gain/Loss:
MIRM
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
GLSI vs. MIRM commentary
Feb 08, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLSI is a StrongBuy and MIRM is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 08, 2026
Stock price -- (GLSI: $29.00 vs. MIRM: $100.47)
Brand notoriety: GLSI and MIRM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GLSI: 43% vs. MIRM: 70%
Market capitalization -- GLSI: $400.26M vs. MIRM: $6.01B
GLSI [@Biotechnology] is valued at $400.26M. MIRM’s [@Biotechnology] market capitalization is $6.01B. The market cap for tickers in the [@Biotechnology] industry ranges from $121.26B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLSI’s FA Score shows that 0 FA rating(s) are green whileMIRM’s FA Score has 1 green FA rating(s).

  • GLSI’s FA Score: 0 green, 5 red.
  • MIRM’s FA Score: 1 green, 4 red.
According to our system of comparison, MIRM is a better buy in the long-term than GLSI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLSI’s TA Score shows that 4 TA indicator(s) are bullish while MIRM’s TA Score has 3 bullish TA indicator(s).

  • GLSI’s TA Score: 4 bullish, 5 bearish.
  • MIRM’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, GLSI is a better buy in the short-term than MIRM.

Price Growth

GLSI (@Biotechnology) experienced а -3.56% price change this week, while MIRM (@Biotechnology) price change was -2.66% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.30%. For the same industry, the average monthly price growth was -2.98%, and the average quarterly price growth was +31.79%.

Reported Earning Dates

GLSI is expected to report earnings on Feb 25, 2026.

MIRM is expected to report earnings on Mar 11, 2026.

Industries' Descriptions

@Biotechnology (-2.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MIRM($6.01B) has a higher market cap than GLSI($400M). GLSI YTD gains are higher at: 38.030 vs. MIRM (27.193). MIRM has higher annual earnings (EBITDA): -2.23M vs. GLSI (-19.58M). MIRM has more cash in the bank: 376M vs. GLSI (3.81M). MIRM has higher revenues than GLSI: MIRM (472M) vs GLSI (0).
GLSIMIRMGLSI / MIRM
Capitalization400M6.01B7%
EBITDA-19.58M-2.23M877%
Gain YTD38.03027.193140%
P/E RatioN/AN/A-
Revenue0472M-
Total Cash3.81M376M1%
Total DebtN/A319M-
FUNDAMENTALS RATINGS
MIRM: Fundamental Ratings
MIRM
OUTLOOK RATING
1..100
48
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
PROFIT vs RISK RATING
1..100
3
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
65

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GLSIMIRM
RSI
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
77%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
73%
Momentum
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
78%
MACD
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
69%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
69%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
82%
Advances
ODDS (%)
Bullish Trend 7 days ago
77%
Bullish Trend 6 days ago
75%
Declines
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
67%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
80%
Bearish Trend 3 days ago
76%
Aroon
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
GLSI
Daily Signal:
Gain/Loss:
MIRM
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
POGRX39.191.23
+3.24%
PRIMECAP Odyssey Growth
ABIEX11.130.22
+2.02%
AB Emerging Markets Multi-Asset I
MDGCX29.200.56
+1.96%
BlackRock Advantage Global Investor A
VARAX10.33N/A
N/A
FirstTrust Merger Arbitrage Cl A
AEPIX28.07N/A
N/A
Allspring Managed Acct Corebuilder EPI

GLSI and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLSI has been closely correlated with STRO. These tickers have moved in lockstep 88% of the time. This A.I.-generated data suggests there is a high statistical probability that if GLSI jumps, then STRO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLSI
1D Price
Change %
GLSI100%
+15.13%
STRO - GLSI
88%
Closely correlated
+6.30%
TERN - GLSI
86%
Closely correlated
+6.88%
ATOS - GLSI
85%
Closely correlated
+0.19%
ACET - GLSI
84%
Closely correlated
+9.16%
IPSC - GLSI
84%
Closely correlated
+1.80%
More

MIRM and

Correlation & Price change

A.I.dvisor indicates that over the last year, MIRM has been closely correlated with RVMD. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if MIRM jumps, then RVMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MIRM
1D Price
Change %
MIRM100%
+2.28%
RVMD - MIRM
72%
Closely correlated
+1.39%
ERAS - MIRM
70%
Closely correlated
+3.45%
TERN - MIRM
70%
Closely correlated
+6.88%
GLSI - MIRM
69%
Closely correlated
+15.13%
STRO - MIRM
68%
Closely correlated
+6.30%
More